Within the secondary analysis, the significantly less conservative but clinically meaningful criterion of stable reaction (defined being a 50% or more reduction in MADRS from baseline for 2 weeks) was used. Of your patients who attained stable response, twenty five.8% while in the esketamine group and fifty seven.6% during the https://jonathanm788vla0.activoblog.com/profile